Cargando…
Methyl 3-(4-bromophenyl)-2-(1H-indol-3-ylmethyl)-5-[1-(4-methoxyphenyl)-4-oxo-2-phenylazetidin-2-yl]-4-nitropyrrolidine-2-carboxylate
In the title compound, C(37)H(33)BrN(4)O(6), the pyrrolidine ring adopts an envelope conformation. The β-lactam ring is planar and makes dihedral angles of 70.16 (13) and 28.32 (13)° with the phenyl and 4-methoxyphenyl rings, respectively. The molecular packing is stabilized by intramolecular C—H...
Autores principales: | , , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
International Union of Crystallography
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2961354/ https://www.ncbi.nlm.nih.gov/pubmed/21202610 http://dx.doi.org/10.1107/S1600536808014190 |
_version_ | 1782188962608054272 |
---|---|
author | Nirmala, S. Kamala, E. Theboral Sugi Sudha, L. Arumugam, N. Raghunathan, R. |
author_facet | Nirmala, S. Kamala, E. Theboral Sugi Sudha, L. Arumugam, N. Raghunathan, R. |
author_sort | Nirmala, S. |
collection | PubMed |
description | In the title compound, C(37)H(33)BrN(4)O(6), the pyrrolidine ring adopts an envelope conformation. The β-lactam ring is planar and makes dihedral angles of 70.16 (13) and 28.32 (13)° with the phenyl and 4-methoxyphenyl rings, respectively. The molecular packing is stabilized by intramolecular C—H⋯O interactions and the crystal packing is determined by intermolecular N—H⋯O hydrogen bonds, and C—H⋯O and C—H⋯π interactions. |
format | Text |
id | pubmed-2961354 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2008 |
publisher | International Union of Crystallography |
record_format | MEDLINE/PubMed |
spelling | pubmed-29613542010-12-30 Methyl 3-(4-bromophenyl)-2-(1H-indol-3-ylmethyl)-5-[1-(4-methoxyphenyl)-4-oxo-2-phenylazetidin-2-yl]-4-nitropyrrolidine-2-carboxylate Nirmala, S. Kamala, E. Theboral Sugi Sudha, L. Arumugam, N. Raghunathan, R. Acta Crystallogr Sect E Struct Rep Online Organic Papers In the title compound, C(37)H(33)BrN(4)O(6), the pyrrolidine ring adopts an envelope conformation. The β-lactam ring is planar and makes dihedral angles of 70.16 (13) and 28.32 (13)° with the phenyl and 4-methoxyphenyl rings, respectively. The molecular packing is stabilized by intramolecular C—H⋯O interactions and the crystal packing is determined by intermolecular N—H⋯O hydrogen bonds, and C—H⋯O and C—H⋯π interactions. International Union of Crystallography 2008-05-17 /pmc/articles/PMC2961354/ /pubmed/21202610 http://dx.doi.org/10.1107/S1600536808014190 Text en © Nirmala et al. 2008 http://creativecommons.org/licenses/by/2.0/uk/ This is an open-access article distributed under the terms of the Creative Commons Attribution Licence, which permits unrestricted use, distribution, and reproduction in any medium, provided the original authors and source are cited. |
spellingShingle | Organic Papers Nirmala, S. Kamala, E. Theboral Sugi Sudha, L. Arumugam, N. Raghunathan, R. Methyl 3-(4-bromophenyl)-2-(1H-indol-3-ylmethyl)-5-[1-(4-methoxyphenyl)-4-oxo-2-phenylazetidin-2-yl]-4-nitropyrrolidine-2-carboxylate |
title | Methyl 3-(4-bromophenyl)-2-(1H-indol-3-ylmethyl)-5-[1-(4-methoxyphenyl)-4-oxo-2-phenylazetidin-2-yl]-4-nitropyrrolidine-2-carboxylate |
title_full | Methyl 3-(4-bromophenyl)-2-(1H-indol-3-ylmethyl)-5-[1-(4-methoxyphenyl)-4-oxo-2-phenylazetidin-2-yl]-4-nitropyrrolidine-2-carboxylate |
title_fullStr | Methyl 3-(4-bromophenyl)-2-(1H-indol-3-ylmethyl)-5-[1-(4-methoxyphenyl)-4-oxo-2-phenylazetidin-2-yl]-4-nitropyrrolidine-2-carboxylate |
title_full_unstemmed | Methyl 3-(4-bromophenyl)-2-(1H-indol-3-ylmethyl)-5-[1-(4-methoxyphenyl)-4-oxo-2-phenylazetidin-2-yl]-4-nitropyrrolidine-2-carboxylate |
title_short | Methyl 3-(4-bromophenyl)-2-(1H-indol-3-ylmethyl)-5-[1-(4-methoxyphenyl)-4-oxo-2-phenylazetidin-2-yl]-4-nitropyrrolidine-2-carboxylate |
title_sort | methyl 3-(4-bromophenyl)-2-(1h-indol-3-ylmethyl)-5-[1-(4-methoxyphenyl)-4-oxo-2-phenylazetidin-2-yl]-4-nitropyrrolidine-2-carboxylate |
topic | Organic Papers |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2961354/ https://www.ncbi.nlm.nih.gov/pubmed/21202610 http://dx.doi.org/10.1107/S1600536808014190 |
work_keys_str_mv | AT nirmalas methyl34bromophenyl21hindol3ylmethyl514methoxyphenyl4oxo2phenylazetidin2yl4nitropyrrolidine2carboxylate AT kamalaetheboralsugi methyl34bromophenyl21hindol3ylmethyl514methoxyphenyl4oxo2phenylazetidin2yl4nitropyrrolidine2carboxylate AT sudhal methyl34bromophenyl21hindol3ylmethyl514methoxyphenyl4oxo2phenylazetidin2yl4nitropyrrolidine2carboxylate AT arumugamn methyl34bromophenyl21hindol3ylmethyl514methoxyphenyl4oxo2phenylazetidin2yl4nitropyrrolidine2carboxylate AT raghunathanr methyl34bromophenyl21hindol3ylmethyl514methoxyphenyl4oxo2phenylazetidin2yl4nitropyrrolidine2carboxylate |